Category: Stock Market

  • This oversold ASX gold developer could more than double: Broker

    Man putting golden coins on a board, representing multiple streams of income.

    Minerals 260 Ltd (ASX: MI6) this week released the results of a prefeasibility study into its Bullabulling gold project in Western Australia, and it’s fair to say the market was underwhelmed.

    While the stock is up more than 440% over the past 12 months, the shares dipped slightly on the publication of the PFS and are now trading at 62 cents.

    The analysts at Morgans believe this is cheap and have a bullish share price target on the gold company’s shares, which we’ll get to later.

    First, let’s look at what they announced.

    Major, long-life gold project in development

    The company said in a statement to the ASX that Bullabulling would generate average annual free cash flow of $330 million and would operate for 19 years.

    The company would spend $180 million from existing cash reserves to get to a final investment decision, while the mine would cost $560 million to build, plus another $115 million for pre-production operations.

    A definitive feasibility study was expected to be completed in the first quarter of calendar year 2027.

    Minerals 260 Managing Director Luke McFadyen said regarding the project:

    Fifteen months after acquiring the Bullabulling Gold Project, we are presenting outcomes of our PFS and a Maiden Ore Reserve. We always believed Bullabulling could become a significant gold operation, and today’s outcomes confirm the potential for this high-margin, large-scale, long-life Project. Our target of delivering Bullabulling into production by the end of 2028 will establish Minerals 260 as the next mid-tier gold producer on the ASX. With an NPV of $2.3 billion, an IRR of 43% and $510M of average annual EBITDA, Bullabulling is set to deliver significant growth and value for our shareholders.

    Shares in this ASX gold company looking cheap

    Morgans said, importantly, that the PFS was completed using the previous 4.5 million-ounce gold resource, with an upgraded 6.2 million-ounce resource providing scope for further resource growth.

    They added:

    The market has reacted negatively to the PFS, which we believe is largely a product of the crystallisation of a sizeable upfront capital requirement rather than any deterioration in project quality. While pre-production capital of ~A$855m is significant, we view it as appropriate for an asset of Bullabulling’s scale, longevity and economic returns, with the project’s strong cash-generative profile expected to support favourable financing outcomes.

    Morgans is anticipating first production in mid FY29 with an average output of about 150,000 ounces per year initially.

    They added:

    We assume a Stage 2 expansion, funded from operating cash flow, is commissioned in 2H FY31, increasing production towards ~200kozpa. Beyond lifting the production profile, the larger-scale operation has the potential to benefit from economies of scale and lower unit operating costs, although we do not currently incorporate these benefits into our base case.

    Morgans has a price target of $1.38 on Minerals 260 shares.

    The post This oversold ASX gold developer could more than double: Broker appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Minerals 260 right now?

    Before you buy Minerals 260 shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Minerals 260 wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 9 ASX 200 shares with reiterated buy calls this week

    Green keyboard button saying buy stock.

    S&P/ASX 200 Index (ASX: XJO) shares are 0.5% higher on Friday at 8,801.8 points.

    Brokers have indicated continuing confidence in several ASX 200 shares this week.

    Let’s take a look.

    Telstra Group Ltd (ASX: TLS)

    The Telstra share price is $4.99, up 0.1% today and up 2.2% over 12 months.

    Morgan Stanley reiterated its buy rating on Telstra shares on Wednesday.

    The broker lowered its 12-month share price target from $5.40 to $5.30.

    This implies potential capital gains of 6% in FY27.

    Liontown Ltd (ASX: LTR)

    The Liontown share price is $1.47, down 0.5% today and up 83% over 12 months.

    The lithium producer was one of the 5 top ASX 200 mining shares for capital growth in FY26.

    Macquarie renewed its buy rating on Liontown shares with a $2.30 target this week.

    This suggests a potential 57% upside ahead.

    Life360 Inc (ASX: 360)

    The Life360 share price is $25.82, down 0.4% today and down 21% over 12 months.

    Citi reiterated its buy rating on Life360 shares on Tuesday.

    The broker raised its target from $28.25 to $31.95.

    This implies potential capital gains of 24% ahead.

    Pro Medicus Ltd (ASX: PME)

    The Pro Medicus share price is $199.48, down 5.1% today and down 37% over 12 months.

    However, that 12-month performance belies this ASX 200 healthcare share’s incredible comeback in CY26.

    Pro Medicus shares hit a 52-week low of $107.75 on 24 February. Since then, they’ve ripped 85% higher.

    And since the broader healthcare sector pivoted on 3 June, Pro Medicus shares have outperformed with a 25% gain.

    That compares to a 21% increase in the S&P/ASX 200 Health Care Index (ASX: XHJ) since 3 June.

    Citi sees more room for growth, and reiterated its buy rating with a $240 target this week.

    This suggests another 20% upside ahead.

    South32 Ltd (ASX: S32)

    The South32 share price is $4.02, up 5.2% today and up 32% over 12 months.

    Morgan Stanley maintained its buy rating on the ASX 200 mining share this week.

    The broker shaved its 12-month target down from $4.85 to $4.75.

    This implies a potential 18% upside ahead.

    BHP Group Ltd (ASX: BHP)

    The BHP share price is $58.28, up 2.5% today and up 52% over 12 months.

    Morgan Stanley renewed its buy rating on BHP shares with a $67.50 target this week.

    This suggests a potential 15% upside in the new financial year.

    WiseTech Global Ltd (ASX: WTC)

    The WiseTech share price is $34.24, down 1.1% today and down 70% over 12 months.

    This tech share was the fastest faller of the ASX 200 in FY26.

    Citi anticipates a strong recovery for WiseTech shares and renewed its buy rating this week.

    However, the broker cut its 12-month target significantly from $65.65 to $52.

    This still implies potential capital gains of 52% in FY27.

    Paladin Energy Ltd (ASX: PDN)

    The Paladin Energy share price is $10.15, up 5.1% today and up 46% over 12 months.

    Morgan Stanley kept its buy call on the ASX 200 energy share but lowered its target from $13.65 to $11.95 this week.

    This suggests a potential 17% upside ahead.

    Coles Group Ltd (ASX: COL)

    The Coles share price is $23.58, down 0.4% today and up 15% over 12 months.

    UBS renewed its buy rating on the ASX 200 consumer staples share with a $25.50 target on Monday.

    This suggests a potential 8% upside ahead.

    The post 9 ASX 200 shares with reiterated buy calls this week appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Life360 right now?

    Before you buy Life360 shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Life360 wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has positions in BHP Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Macquarie Group, and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360, Telstra Group, and WiseTech Global. The Motley Fool Australia has recommended BHP Group, Macquarie Group, and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • How high does Macquarie think this ASX drone technology company will go?

    A silhouette of a soldier flying a drone at sunset.

    Most investors wouldn’t think of drones initially when thinking of Codan Ltd (ASX: CDA), with the company having traditionally based its business around radio communications technology and metal detector sales.

    But the company’s DTC division, which it acquired back in 2021, has developed radio technology for use on drone platforms, which has piqued the interest of the analysts at Macquarie.

    Major opportunity for ASX drone players

    The Macquarie team said in a recent note to clients that there is expected to be exponential growth in drone spending, citing a recent NATO initiative called “drone edge”, which envisages US$40 billion worth of investment in the sector from more than 30 countries.

    They added:

    As we mentioned in a previous report, the US Department of War’s 2027 budget overview includes US$53.6bn in funding for drone and autonomous systems and US$21bn for counter drone technologies. This dedicated investment into autonomous systems’ procurement, domestic production capacity and advanced capabilities is being divided across multiple specialised programs.

    They said in relation to Codan:

    When encompassing estimated communication layer drone costs and US-specific programs, together these frame a large, multi-year, structurally growing US demand pool that plays directly to DTC’s niche. DTC’s key offering of resilient datalink, mesh-networking and electronic warfare hardened communications layer is directly linked to various components that multi-domain drone and unmanned systems require.

    The Macquarie team said beyond the US, “DTC also has significant opportunities in the European region as noted by management back at the 1H26 result”.

    They added:

    Europe has emerged as a structurally attractive opportunity as the recent step-change in defence spending driven by the war in Ukraine and NATO eastern-flank deterrence is flowing into unmanned-systems and resilient communications categories where DTC competes.

    Macquarie said the Asia-Pacific region was also shaping up as one of the most compelling regions for DTC, driven by a surge in defence spending.

    Australia itself was a “high-conviction oppoprtunity”, with the company’s radios already selected for the Land 129 UAV project.

    Macquarie added regarding the company:

    To meet surging international demand for secure communications solutions as a part of the increasing demand for drones and uncrewed systems, DTC has established a multi-country manufacturing footprint, expanding production outside the US. The newer established manufacturing locations for DTC, the United Kingdom and Australia, help to de-risk global supply chains. This expansion in manufacturing positions DTC well to capture opportunities across different regions globally.

    Shares looking cheap

    Macquarie has a price target of $48.50 on Codan shares compared with $43.25 currently.

    The company is valued at $8.09 billion.

    The post How high does Macquarie think this ASX drone technology company will go? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Codan right now?

    Before you buy Codan shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Codan wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why record production could not save this ASX lithium stock today

    Lithium mine drilling machines.

    Elevra Lithium Ltd (ASX: ELV) shares are slipping on Friday after the lithium producer released an early look at its June quarter.

    At the time of writing, the Elevra Lithium share price is down 4.54% to $8.62. By comparison, the S&P/ASX 200 Index (ASX: XJO) is up 0.5% to 8,809 points.

    Despite today’s decline, Elevra shares remain up around 7% in 2026 and have climbed roughly 220% since this time last year.

    The latest numbers included another strong quarter at the mine, although the lower price received for its lithium appears to be weighing on the stock.

    Here’s what the company reported.

    Production finishes the year strongly

    According to the release, Elevra produced approximately 54,479 dry metric tonnes (dmt) of spodumene concentrate during the June quarter.

    Production rose 15% from the March quarter and marked the second-highest quarterly result achieved at North American Lithium.

    The operation delivered a particularly strong May, producing approximately 22,202 tonnes. Elevra described this as a monthly production record.

    Full-year production reached approximately 197,968 tonnes, giving the company a stronger finish to FY26.

    Management put the improvement down to continued work on plant optimisation, ore feed consistency, and recoveries. The company also pointed to throughput and operating efficiency gains across the quarter.

    However, sales didn’t keep pace with production.

    Sales came in at around 33,977 tonnes, which the company linked to customer delivery schedules.

    As a result, Elevra finished June with a provisional inventory of around 40,863 tonnes.

    Pricing takes the shine off production gains

    The price Elevra received for its lithium was less than impressive.

    The company reported provisional average realised pricing of approximately US$919 per tonne, sold free on board.

    Management said June shipments were priced under contracts linked to average market prices between October 2025 and March 2026.

    Lithium prices were lower through much of that period, which left Elevra receiving less than the current spot market.

    The June quarter sales were also made under the company’s largest legacy contract, which uses the same delayed pricing structure.

    Currently, the spot price for lithium is sitting at 158,500 CNY, down 3.35% for the day.

    Can Elevra shares recover?

    I think Elevra shares can recover from here.

    Production is improving, and the pricing lag should start to ease as more sales move onto newer contracts.

    The next step is to turn that higher output into better sales and cash flow, particularly after inventory increased during the quarter.

    The full quarterly report later this month should show whether higher production is starting to improve the rest of the business.

    The post Why record production could not save this ASX lithium stock today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Elevra Lithium right now?

    Before you buy Elevra Lithium shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Elevra Lithium wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Here’s what brokers tip for BHP shares over the next 12 months

    An engineer takes a break on a staircase and looks out over a huge open pit coal mine as the sun rises in the background.

    BHP Group Ltd (ASX: BHP) shares are rising strongly on Friday, up 2.2% to $58.09 apiece.

    FY26 was a big year for the ‘Big Australian’.

    The BHP share price soared 62% in FY26 to finish at $59.40 on 30 June.

    BHP was one of the strongest performers for capital growth amongst the ASX 200 large-cap shares last year.

    The company benefited from a rotation into mining stocks, as well as an 18% rise in the copper price and a 7% increase in the iron ore price.

    While BHP is still a major iron ore producer, it is also now the world’s largest copper producer.

    Copper, essential for electrification, rose to a record US$6.60 per pound in May amid high demand due to the green energy transition.

    In 1H FY26, copper made up for more than half of BHP’s underlying earnings before interest, taxes, depreciation, and amortisation (EBITDA)

    In its 3Q FY26 update, BHP said strong production at Escondida in Chile and Antamina in Peru meant it expected group production for full-year FY26 would be at the upper end of its guidance.

    There was mixed news relating to other parts of the business in FY26.

    In February, BHP announced a long-term silver streaming agreement with Wheaton Precious Metals Corp (NYSE: WPM).

    The miner received US$4.3 billion upfront, which strengthened the balance sheet, for a share of its silver from Antamina.

    But there was trouble at the Jansen potash project in Canada. In June, BHP revealed a US$2 billion estimated cost blow-out for Stage 2.

    The miner said it now expected Stage 2 to cost US$6.9 billion, up from the previous estimate of US$4.9 billion.

    Jansen Stage 1 remains on track for first production in FY27.

    In March, we learned that CEO Mike Henry would be stepping down on 1 July after six-and-a-half years at the helm.

    He was replaced by Brandon Craig, who has worked at BHP for 25 years and was formerly President of the Americas division.

    In May, BHP took back its crown as the ASX 200’s largest company by market cap from Commonwealth Bank of Australia (ASX: CBA).

    What do the experts think about BHP shares?

    Looking ahead to FY27, brokers have a mixed view on whether BHP shares are a buy, hold, or sell.

    They also offer a range of 12-month price targets on the ASX 200 mining share.

    Let’s start with some consensus views, then hear some explanations from individual analysts regarding their ratings.

    On the TradingView platform, there is a consensus neutral rating (equivalent to a hold call) from 20 analysts.

    Four analysts give BHP shares a strong buy rating, 13 say hold, two say sell, and one analyst has a strong sell rating.

    The 12-month share price targets among those 20 analysts range from $43.94 to $94.10.

    On the CommSec trading platform, 19 analysts provide a hold consensus rating.

    Four give the miner a strong buy rating, 14 say hold, and there is one strong sell recommendation.

    Who says buy, and why?

    Morgan Stanley maintained its buy rating on BHP shares with a 12-month price target of $67.50 yesterday.

    Deutche Bank also gives BHP shares a buy call, and raised its target from $50.25 to $52.19 earlier this month.  

    Blake Halligan from Catapult Wealth also has a buy rating on BHP shares and explains why:  

    The global miner holds dominant positions in iron ore and copper and is leveraged to increasing demand during the energy transition.

    Despite the Jansen impairment and the risk of industrial action at iron ore operations in the Pilbara region of Western Australia, near term earnings momentum remains strong.

    The balance sheet remains robust with low net debt, while a recent dividend yield above 3 per cent adds income appeal.

    Who has a hold call on BHP shares?

    Hold is the dominant rating among the experts today.

    Morgans reiterated its hold call on BHP shares yesterday, and increased its 12-month target from $54.90 to $59.80.

    Bank of America, which has a history of optimistic price targets on BHP shares, reiterated its hold rating on Wednesday and reduced its target from $70 to $65.

    Other analysts who reiterated hold calls but reduced their targets this week include Citi, from $66 to $63, and Jefferies, from $68 to $65.

    Meanwhile, Macquarie stayed at $55, and UBS remained at $60 per share.

    The most pessimistic target we found was $40.10, suggested by Barclays this week. This implies a potential 30% downside in FY27.

    On The Bull, Remo Greco from Sanlam Private Wealth explained why he has a hold rating on BHP shares:

    Several disappointing events have led us to downgrade BHP to a hold.

    Cost over-runs at its Jansen stage 2 potash project in Canada lifts the investment cost by about $US2 billion to $US6.9 billion. Possible industrial action, although averted in June, may re-ignite at the company’s iron ore operations in the Pilbara region of Western Australia.

    Any industrial action may impact stock performance.

    Longer term, we like BHP’s exposure to copper – the key metal of the future.

    James Bills from Shaw and Partners also has a hold rating and commented:  

    BHP remains a cornerstone of the Australian sharemarket, underpinned by its scale, diversified commodity exposure and strong balance sheet.

    While iron ore continues to drive earnings, BHP is increasingly leveraged to future-facing commodities, including copper, where demand is expected to increase significantly due to growth in data centres and electric vehicles.

    Despite near term volatility in commodity prices and sensitivity to global growth, the company’s disciplined capital management and strong cash generation support shareholder returns.

    Holding remains appropriate given its quality asset base and exposure to long term structural demand trends.

    Michael Gable from Fairmont Equities recommends holding BHP shares because “the commodities bull market is still in the early stages of the latest cycle”.

    Experts say there are five fundamentals driving this new commodities supercycle. Learn more about them here.

    The post Here’s what brokers tip for BHP shares over the next 12 months appeared first on The Motley Fool Australia.

    Should you invest $1,000 in BHP Group right now?

    Before you buy BHP Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and BHP Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Citigroup is an advertising partner of Motley Fool Money. Bank of America is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has positions in BHP Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Jefferies Financial Group and Macquarie Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Barclays Plc. The Motley Fool Australia has recommended BHP Group and Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why this ASX software stock is rocketing 13% today

    Man on a ladder drawing an increasing line on a chalk board, symbolising a rising share price.

    Bravura Solutions Ltd (ASX: BVS) shares have taken off on Friday after the financial software company delivered a better-than-expected FY26 earnings update.

    At the time of writing, the Bravura share price is up 13.17% to $2.32. By comparison, the S&P/ASX 300 Index (ASX: XKO) is currently sitting at 8,705 points, 0.1% higher.

    The rally comes after a fairly ordinary start to the year. Bravura shares remain down around 20% in 2026, although they are still 8% higher than this time last year.

    Here’s what the company is now forecasting.

    Bravura lifts its earnings outlook

    According to the release, Bravura now expects FY26 cash EBITDA of approximately $77 million.

    This is above its previous guidance range of $69 million to $73 million and has given the market something positive to work with.

    Revenue guidance has been left unchanged at $280 million to $285 million, while capital expenditure is still expected to be roughly $4 million.

    Bravura put the better result down to steady demand for project work and tighter control over costs.

    Management has used an average GBP/AUD exchange rate of 1.92 for the second half, compared with 1.95 in its previous guidance.

    The full-year result is due on 12 August, when investors will get a closer look at how the business finished FY26.

    Bravura’s recovery moves forward

    The earnings upgrade comes after a fairly unsettled period at Bravura.

    Former Chairman Matthew Quinn retired last year following tensions with L6 Holdings, which owns more than 20% of the company.

    L6 is controlled by Damien Leonard, who runs Pinetree Capital and is the son of Constellation Software founder Mark Leonard.

    Damien Leonard now sits on Bravura’s board as a Director.

    Bravura has also spent the past few years reshaping the business after its shares fell heavily in 2022.

    The company has spent the past few years cutting costs, reducing headcount, and simplifying the business. It has also placed more focus on its core wealth management software operations to improve margins and cash flow.

    Is the worst behind Bravura?

    The 13% jump suggests investors are warming to the progress Bravura is making.

    The company is producing stronger earnings, while lower costs are helping lift margins and supporting profitability.

    The share price is still well below where it traded before the 2022 collapse, so I think there is room for a further recovery if the company keeps improving.

    The August result will give investors a better idea of whether Bravura can carry this momentum into the new financial year.

    The post Why this ASX software stock is rocketing 13% today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Bravura Solutions right now?

    Before you buy Bravura Solutions shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Bravura Solutions wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Bravura Solutions and Constellation Software. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • How to give your kids a superannuation kickstart, with help from the government

    A wad of $100 bills of Australian currency lies stashed in a bird's nest.

    Saving for their retirement is probably the last thing on your children’s minds when they first start working, but there is a good reason to get them signed up for a superannuation account early.

    Most younger teens are not automatically eligible for superannuation payments from their employer, as workers aged under 18 must work more than 30 hours per week to be eligible for super.

    This changes once they turn 18, when all workers must be paid 12% super regardless of the number of hours worked.

    Government money on the table for super

    But just because they don’t get paid super, doesn’t mean there isn’t a great reason to sign your children up for a super account.

    This is because, as low-income earners, they will likely be eligible for a super co-contribution from the government if they make an after-tax contribution themselves.

    There are some rules, including that, for 2026-27, they must earn less than $49,293 to receive the full $500 government contribution.

    There is also the 10% eligible income test, which states that 10% or more of your total income must come from either employment-related activities or carrying out a business.

    To be eligible for the full $500 contribution from the government, $1000 in non-concessional (after-tax) contributions must be made.

    Compound interest works its magic

    And while $500 might not sound like a lot, the impact on your child’s retirement savings could be huge.

    Using the government’s Moneysmart website, I have calculated that $500 deposited into a 15-year-old’s account will turn into $10,500 by the age of 60, assuming the initial deposit compounds at 7% per year.

    And remember, this is calculated assuming just one year of contributions.

    The Australian Taxation Office website says your children do not need to do anything to receive the payment, and can make smaller payments throughout the year.

    As they say:

    You don’t need to make your personal contributions as a single lump sum – you can make payments throughout the financial year. We use the total amount you have contributed for the year to calculate the co-contribution. Your super fund can tell you how to make personal contributions, and it will need your tax file number before it can accept them.

    The minimum contribution that can be made is $20, and the government has a calculator to help people figure out how much they will be paid.

    The post How to give your kids a superannuation kickstart, with help from the government appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • This ASX silver mine developer could more than triple in value: Broker

    Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.

    Silver Mines Ltd (ASX: SVL) is progressing its Bowdens silver project in the central west region of New South Wales, and expects to release its definitive feasibility study on the project imminently.

    The analyst team at Morgans has run the ruler over the project and has come up with a very bullish share price target on Silver Mines shares, which we’ll get to shortly.

    First, let’s have a look at why Morgans like the company so much.

    Large silver project progressing toward development

    Morgans said Silver Mines’ Bowdens project is Australia’s largest undeveloped silver resource and one of the largest globally.

    The deposit also remains open beyond the current mining plan, “leaving room for reserve growth, mine life extension and underground potential”.

    Morgans notes that direct silver exposure is rare among ASX miners, and in this case, “with silver contributing ~86% of life-of-mine revenue, Bowdens is one of the purest ways to gain leverage to rising silver prices through an advanced Australian development asset”.

    The broker has modelled free cash flow of $1.63 billion over the life of the mine, and added, “we expect the upcoming Definitive Feasibility Study (DFS) to further refine the development pathway and potentially unlock additional value through updated pricing assumptions, optimisation initiatives and mine life extensions”.

    They added:

    We forecast first production in FY30, providing sufficient time for completion of the revised approvals process, project financing and construction. Following multiple engineering studies, metallurgical programmes and optimisation work, we consider Bowdens a technically mature development asset, leaving permitting and financing as the principal remaining milestones.

    Shares looking cheap

    Morgans has a 40 cent per share price target on Silver Mines, compared to the current price of 12.5 cents per share.

    The broker said that the market, “continues to undervalue Bowdens’ combination of scale, technical maturity and leverage to a structurally improving silver market”.

    They added:

    While permitting remains the dominant risk, we believe this is increasingly offset by a more clearly defined approvals pathway, an advanced stage of project development, and multiple near term catalysts capable of reducing the regulatory discount currently reflected in the share price. Our thesis rests on what we view as an increasingly compelling asymmetry in Bowdens’ risk-reward profile, underpinned by exceptional leverage to a strengthening silver price, a technically mature development plan and a more clearly defined permitting pathway.

    They added that their valuation only reflects a portion of the company’s broader options including further open pit cutbacks and potential resource growth.

    Silver Mines is currently valued at $277.42 million.

    The post This ASX silver mine developer could more than triple in value: Broker appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Silver Mines right now?

    Before you buy Silver Mines shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Silver Mines wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Could this ASX copper share really rise 400%?

    Pile of copper pipes.

    Shares in Caravel Minerals Ltd (ASX: CVV) have improved more than 39% over the past year, but they’re still trading well off their highs over the period.

    But the analyst team at Shaw and Partners has recently initiated coverage on the ASX copper stock and believes shareholders should persist, predicting serious share price upside for the company.

    Major copper project in development

    So what does Caravel do? The company is currently finalising the definitive feasibility study for its Caravel copper project 150km northeast of Perth.

    Shaw and Partners said in its recent research report that Caravel was one of the largest undeveloped copper resources globally.

    They added:

    The project is a large-scale, low-cost operation that will utilise bulk mining and automation to drive strong unit cost efficiencies, supported by its proximity to Perth, only 150km away. With a Tier-1 resource, progressing permitting and emerging strategic funding interest, Caravel is well positioned to develop a globally significant copper operation leveraged to ongoing structural demand growth from electrification, EVs and AI.

    Shaw and Partners said a key advantage for the project was its proximity to established infrastructure which was unusual for projects of this size.

    They added:

    Located within trucking distance of Perth and connected to existing sealed roads, power infrastructure and skilled labour pools, the project avoids many of the logistical challenges faced by more remote copper developments. This infrastructure access significantly lowers capital intensity and operating risk relative to comparable greenfield projects.

    Shaw and Partners said Caravel was progressing funding options while the definitive feasibility study was being finalised, “with the project’s scale and long mine life lending itself to a diversified capital stack”.

    They added:

    Caravel will pursue a mix of project debt, strategic investment and potential offtake-linked financing, to minimise dilution while providing the balance sheet required for construction. Strong interest from potential strategic partners and lenders, highlighted by the Adani non-binding MoU, reflects growing global demand for secure copper supply. This positioning enables Caravel to assemble a robust funding structure as development decisions approach.

    Shaw and Partners said the growing demand for copper supported the reasons to buy ito the stock.

    They said rapid growth in renewable energy, the electrification of transport and, “the rising power intensity of AI-driven data centres are expected to drive sustained copper consumption over the short, medium and long-term”.

    The project also had significant precious metal and molybdenum by-products, Shaw and Partners said.

    The broker has a $1.15 share price target on Caravel shares, which would be a 400% gain from the current share price of 23 cents.

    Caravel is valued at $128.5 million.

    The post Could this ASX copper share really rise 400%? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Caravel Minerals right now?

    Before you buy Caravel Minerals shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Caravel Minerals wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Mesoblast shares: Q4 earnings top projections

    a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.

    The Mesoblast Ltd (ASX: MSB) share price is in focus today after the company reported fourth-quarter net revenue of US$36 million, boosting full-year revenue to US$115 million for the period ended 30 June 2026.

    What did Mesoblast report?

    • Fourth quarter net revenue: US$36 million
    • Full-year net revenue: US$115 million
    • Ryoncil® uptake exceeded initial projections
    • Strong capital position and funding for operations

    What else do investors need to know?

    Ryoncil® is the first mesenchymal stromal cell (MSC) product approved by the US FDA for any indication and remains the only FDA-approved option for children under 12 with steroid-refractory acute graft-versus-host disease (SR-aGvHD). This achievement has positioned Mesoblast as a leading developer of allogeneic cellular medicines targeting severe inflammatory diseases.

    The company’s manufacturing capabilities continue to deliver industrial-scale, off-the-shelf cellular medicines. Mesoblast also has an extensive intellectual property portfolio, with patents that provide commercial protection through to at least 2044 in key markets.

    What’s next for Mesoblast?

    Looking ahead, Mesoblast expects continued revenue growth, supported by momentum across major US paediatric centres. The company’s robust capital base and new five-year facility are intended to support further strategic initiatives, including label extensions and new blockbuster product launches.

    Mesoblast is advancing its Ryoncil® therapy for additional inflammatory diseases, such as SR-aGvHD in adults and biologic-resistant inflammatory bowel disease, while its rexlemestrocel-L platform targets heart failure and chronic low back pain.

    Mesoblast share price snapshot

    Over the past 12 months, Mesoblast shares have risen 27%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 2% over the same period.

    View Original Announcement

    The post Mesoblast shares: Q4 earnings top projections appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Mesoblast right now?

    Before you buy Mesoblast shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Mesoblast wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.